MediPharm Labs Corp. (TSX:LABS)

Canada · Delayed Price · Currency is CAD

0.0650

0.00 (0.00%)

Oct 15, 2026, 3:59 PM EST

MediPharm Labs Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	28	27	25	26	20	50
Market Cap Growth	-17.51%	10.87%	-5.43%	32.06%	-60.54%	-39.28%
Enterprise Value	18	16	12	15	1	14
Last Close Price	0.07	0.07	0.06	0.07	0.07	0.18

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	22.71	22.71	22.71	22.71	22.71
PS Ratio	0.67	0.61	0.59	0.79	0.89	2.31
PB Ratio	0.78	0.76	0.57	0.49	0.35	0.60
P/TBV Ratio	0.80	0.78	0.58	0.50	0.35	0.60

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.43	0.37	0.28	0.44	0.07	0.66

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.01	0.00
Net Debt / Equity Ratio	-0.28	-0.31	-0.27	-0.30	-0.43	-0.42
Net Debt / EBITDA Ratio	4.15	2.00	1.55	1.46	0.97	0.87
Net Debt / FCF Ratio	9.58	1.99	2.29	1.25	1.43	2.50
Asset Turnover	0.87	0.91	0.71	0.51	0.28	0.21
Inventory Turnover	3.01	3.81	3.17	2.83	2.58	2.12
Quick Ratio	1.68	1.90	1.85	2.22	4.01	5.88
Current Ratio	2.69	2.77	3.15	3.37	5.01	7.38
Return on Equity (ROE)	-13.22%	-20.93%	-22.23%	-24.00%	-43.09%	-67.84%
Return on Assets (ROA)	-5.17%	-9.07%	-10.55%	-12.87%	-21.99%	-27.14%
Return on Invested Capital (ROIC)	-15.70%	-25.63%	-28.90%	-38.73%	-69.56%	-74.34%
Return on Capital Employed (ROCE)	-11.10%	-20.20%	-23.00%	-25.10%	-49.60%	-54.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-17.91%	-30.23%	-43.35%	-50.16%	-151.80%	-109.48%
FCF Yield	-3.76%	-20.49%	-20.33%	-49.11%	-85.72%	-27.96%
Buyback Yield / Dilution	-2.31%	-2.53%	-12.29%	-31.23%	-10.79%	-80.37%